Skip to content
Open access

Active surveillance versus standard surgery after neoadjuvant chemoradiotherapy for oesophageal cancer: long-term results of a cluster-randomised controlled trial (SANO).

S. S. G. Gangaram Panday B. J. van der Wilk S. Lagarde B. Eyck C. Rosman B. Noordman M. Valkema T. M. Bisseling P. Coene M. V. van Det J. Dekker J. V. van Dieren M. Doukas S. van Esser W. Fiets H. Hartgrink J. Heisterkamp I. Holster B. Klarenbeek E. Kouw E. Kouwenhoven M. Luyer B. Mostert G. Nieuwenhuijzen L. Oostenbrug J. Pierie J. V. van Sandick M. Sosef M. Spaander R. Valkema E. S. van der Zaag E. Steyerberg D. van Klaveren B. Wijnhoven J. J. van Lanschot A. Koch Suzan Nikkessen Ate van der Gaast Katharina Biermann Lindsey Oudijk H. Lingsma Roy S. Dwarkasing J. Nuyttens Pieter C. van der Sluis G. Bulte P. Siersema Harm Westdorp Erik H. Aarntzen Chella S. van der Post Maartje C. van Rijk P. Braam H. Rütten Marcel Verheij Serge J. Zweers Lieke Hol Ewout F. W. Courrech Staal Karen E. Hamoen Trudy Rapmund Erwin van der Harst Andries van der Linden Huseyin Aktas Polat Dura R. Hoekstra Ali Agool Joop van Baarlen Ellen M. Hendriksen Henk Jan Mantel Rutger Quispel Sanna A. Mulder Arjan J. Verschoor Marc R. J. ten Broek René J. Dallinga Irene M. Lips Erlinde de Graaf Thomas R. de Wijkerslooth Marieke A. Vollebergh Emilia C. Owers Annemarieke Bartels-Rutten L. Kodach Francine E. M. Voncken Yvonne Hilhorst Marjolein Warmerdam Sietske Corporaal Marco B. Polée Anne Marij G. van Burg Judith Nieken Rinze Wolf Vera Oppedijk Marloes Emous Daniel A. Hess Willemien Erkelens S. Cathrien S. Tromp-van Driel Marc D. Zuijdwijk H. Doornewaard K. Muller Peter van Duijvendijk Eelco B. Wassenaar Wouter L. Curvers Geert-Jan Creemers Mark J. Roef Ineke van Lijnschoten J. Nederend Maurice J. C. van der Sangen Tom C. G. Budiharto Fanny F. B. M. Heesakkers Khalida Soufidi F. Warmerdam Wendy Schreurs R. Riedl R. Vliegen J. Buijsen Ilse Stohr Eric H. J. Belgers Jolein van der Kraan M. Slingerland Richard Raghoo A. Crobach A. J. van der Molen Susan J. C. L. M. Quix Wobbe O. de Steur Wouter L. Hazen Laurens V. Beerepoot D. Ploeg T. Rozema Ilse A. C. Vermeltfoort W. Jansen
Oct 2026 · Annals of Oncology · 0 citations · 28 references
Medicine

Abstract

Background

The Surgery As Needed for Oesophageal cancer (SANO)-trial demonstrated that active surveillance is non-inferior to standard surgery in terms of two-year overall survival in patients with a complete clinical response after neoadjuvant chemoradiotherapy (nCRT). Active surveillance resulted in improved quality of life. Here, we report five-year outcomes.

Methods

From 2017 to 2021, a multicentre stepped-wedge cluster-randomised non-inferiority trial was conducted. Patients with locally advanced oesophageal cancer who achieved complete clinical response (defined as no tumour detected on endoscopic biopsies, -ultrasound, or PET-CT) underwent active surveillance or standard surgery. Cox regression was used to compare five-year overall and disease-free survival, and the cumulative incidence of distant metastases was estimated using competing risk analysis.

Results

A total of 309 patients were included, 198 underwent active surveillance and 111 underwent standard surgery. Median follow-up was 76 months (IQR 67-86). Five-year overall survival was not statistically significantly different between active surveillance and standard surgery (50%, 95%CI 43-57 vs. 54%, 95%CI 46-64; HR 1.17, 95%CI 0.77-1.77) with similar results across histologic subtypes. Disease-free survival was not statistically significantly different (HR 1.39, 95% CI 0.94-2.06). The cumulative incidence of distant metastases at five years was significantly higher in the active surveillance group compared to the standard surgery group (46%, 95%CI 39-53 vs. 29%, 95%CI 21-37; P<.01). Overall, 85 of 198 patients (43%) avoided oesophagectomy, including those with sustained complete clinical response at last follow-up or distant metastases detected within six months after nCRT.

Conclusions

Overall survival at five years is not statistically significantly different between active surveillance and standard surgery in patients with oesophageal cancer and a complete clinical response after nCRT, despite a higher incidence of distant metastases in the active surveillance group. These findings support active surveillance as a feasible treatment strategy in selected patients.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.